{Reference Type}: Journal Article
{Title}: A rapid and validated GC-MS/MS method for simultaneous quantification of serum Myo- and D-chiro-inositol isomers.
{Author}: Wang X;Lu L;Peng H;Li T;Long Q;Guan L;Xia X;Li X;Wang M;
{Journal}: J Chromatogr A
{Volume}: 1732
{Issue}: 0
{Year}: 2024 Sep 13
{Factor}: 4.601
{DOI}: 10.1016/j.chroma.2024.465246
{Abstract}: <B>BACKGROUND: </B>Myo-inositol (MI) and D-chiro-inositol (DCI) are two paramount isomers of inositol, both vital in glucose and steroid metabolism. Deficits in MI, DCI or MI/DCI ratio are expressly concerned with several pathological process, whereas MI and DCI lack practical measurement for human specimen.<BR><B>METHODS: </B>To quantify MI and DCI in serum samples simultaneously, a gas chromatography tandem mass spectrometry (GC-MS/MS) method was established. The process flow was optimized in ion source, derivative agent volume and reaction time. The performance characteristics were verified by commercial standards and clinical serums.<BR><B>RESULTS: </B>This method was confirmed to be sensitive (LOD ≤ 30 ng/mL of MI, ≤3 ng/mL of DCI) and reproducible (RSD < 6 % for repeated analyses). Quantitative determinations performed good linearity within the measurement range of 0.500-10.00 and 0.005-0.500 μg/mL for MI and DCI respectively (R2 > 0.999). The recoveries of MI and DCI were 97.11-99.35 % and 107.82-113.09 %, respectively. This method was successfully applied to 114 clinical specimens. No significant matrix effect was observed in serum samples under current conditions.